
Monoclonal Antibody Infusions Were Helping Patients—Why Did the Government Pull Back? ER Doctor and Whistleblower Explain
Monoclonal antibody infusions were helping patients. So why did access change—and what happened to the people waiting for treatment?
On NursesOutLoud, Jodi O’Malley, MSN, RN, welcomes ER physician Dr. Ron Elfenbein and corporate whistleblower John D. White for a conversation about COVID treatment access, canceled infusions, and the fight for accountability.
Dr. Elfenbein recounts running community infusion clinics and having to cancel roughly 250 scheduled treatments during the December 2021 disruption. White discusses his allegations concerning federal contracts and pharmaceutical interests…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.